Sahaj Regenerative Cell Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
as on 26-12-2024
- Paid Up Capital ₹ 7.20 Cr
as on 26-12-2024
- Company Age 11 Months 9 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.82 Cr
as on 26-12-2024
About Sahaj Regenerative Cell Therapeutics
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 7.20 Cr.
The company currently has active open charges totaling ₹2.82 Cr.
Priti Jain, Vinod Jain, Sulochana Bohara, and One other member serve as directors at the Company.
- CIN/LLPIN
U86201MP2024PTC069544
- Company No.
069544
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Jan 2024
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sahaj Regenerative Cell Therapeutics?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Priti Jain  | Director | 30-Jan-2024 | Current |
| Vinod Jain | Director | 30-Jan-2024 | Current |
| Sulochana Bohara | Director | 30-Jan-2024 | Current |
| Raj Sharma | Director | 05-Feb-2024 | Current |
Financial Performance of Sahaj Regenerative Cell Therapeutics.
Enhance accessibility to Sahaj Regenerative Cell Therapeutics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sahaj Regenerative Cell Therapeutics?
Unlock access to Sahaj Regenerative Cell Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sahaj Hospitals Private LimitedActive 16 years 4 monthsPriti Jain and Sulochana Bohara are mutual person
- Sahaj Innovative Cell Therapy Private LimitedActive 9 years 7 months
Priti Jain and Sulochana Bohara are mutual person
- Hope Diagnostic And Fertility Centre Private LimitedActive 22 years 1 month
Priti Jain and Vinod Jain are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Kotak Mahindra Bank Limited Creation Date: 24 Jul 2017 | ₹2.82 Cr | Open |
How Many Employees Work at Sahaj Regenerative Cell Therapeutics?
Sahaj Regenerative Cell Therapeutics has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sahaj Regenerative Cell Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sahaj Regenerative Cell Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.